| 3.46 Data as of 4:00pm ET |  +0.05 / +1.47%Today’s Change | 2.47 Today|||52-Week Range 6.89 | +29.10% Year-to-Date |
| Previous close | 3.41 |
| Today’s open | 3.40 |
| Day’s range | 3.38 - 3.46 |
| Volume | 229,770 |
| Average volume (3 months) | 552,780 |
| Market cap | $169.2M |
| Dividend yield | -- |
| Earnings growth (last year) | +16.41% |
| Earnings growth (this year) | -32.18% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -14.10% |
| P/E ratio | NM |
| Price/Sales | 6.63 |
| Price/Book | 2.45 |
| Today’s change | Today’s % change | |
|---|---|---|
| STMLStemline Therapeutic... | -0.17 | -1.16% |
| OMTHOmthera Pharmaceutic... | +0.20 | +2.92% |
| TTPHTetraphase Pharmaceu... | 0.00 | 0.00% |
| AMPEAmpio Pharmaceutical... | +0.15 | +3.21% |
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | -$0.35 |
| Annual revenue (last year) | $18.4M |
| Annual profit (last year) | -$48.8M |
| Net profit margin | -264.98% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer John F. Crowley, MBA |
Chief Financial Officer William D. Baird, III, MBA |
Corporate headquarters Cranbury, New Jersey |
.
